MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    A Comparative Study of Measured and Predicted Metrics of Respiratory Function in People with Parkinson’s Disease (PD)

    L. Mcmahon, O. Lennon, C. Blake, D. Mcgrath (Dublin, Ireland)

    Objective: The objective of this research was to compare measured metrics of respiratory function – Spirometry, Respiratory Muscle Strength and Peak Cough Flow – with…
  • 2019 International Congress

    The radiofrequency (RF)-induced heating profile of an externalized, directional DBS lead using functional imaging sequences in an Intraoperative Magnetic Resonance Imaging Suite (IMRIS)

    P. Bhattacharyya, S. Jones, M. Lowe, M. Deblock, A. Machado, K. Baker (Cleveland, OH, USA)

    Objective: To characterize the RF-induced heating profile of the St. Jude Infinity lead within an IMRIS using a configuration that emulates intraoperative functional MRI during…
  • 2019 International Congress

    Evaluating Volume Changes in the Substantia Nigra Pars Compacta (SNc) in Parkinson’s Disease (PD) in a Study-Specific Magnetic Resonance Imaging (MRI) Template

    E. Biondetti, R. Gaurav, L. Yahia-Cherif, G. Mangone, N. Pyatigorskaya, R. Valabregue, C. Ewenczyk, M. Hutchison, JC. Corvol, MJ. Vidailhet, S. Lehéricy (Paris, France)

    Objective: To characterize the topography of SNc involvement in PD patients using neuromelanin (NM)-sensitive MRI (NM-MRI). Background: PD is characterized by the progressive loss of…
  • 2019 International Congress

    Decreased Cannabinoid Type 1 Receptor Density in Parkinson’s Disease: A [18F]FMPEP-d2 PET Study

    A. Brück, H. Al-Abdulrasul, J. Tuisku, R. Ajalin, J. Hirvonen, J. Rinne (Turku, Finland)

    Objective: To explore type 1 endocannabinoid receptor (CB1R) expression in subjects with Parkinson’s disease (PD) and healthy controls using [18F]FMPEP-d2 PET. Background: CB1Rs are expressed…
  • 2019 International Congress

    Whole-Body Neuromuscular Ultrasound for Evaluating Posture and Targeted Management of Muscle Spasticity and Pain

    R. Bubnov, L. Kalika (Kyiv, Ukraine)

    Objective: The aim was to assess efficacy of whole body neuromuscular ultrasound to evaluate posture and targeted management of muscle spasticity and pain. Background: Muscle…
  • 2019 International Congress

    Neuroanatomical correlates of early cognitive change in Parkinson’s disease

    E. Bunting, L-A. Leyland, R. Weil (London, United Kingdom)

    Objective: To identify the neuroanatomical basis of early cognitive change in Parkinson’s disease (PD). Background: 50% of PD patients develop dementia within 10 years of…
  • 2019 International Congress

    Arterial spin labelling detects subcortical hypoperfusion in early drug-naïve patients with Parkinson’s disease

    SP. Caminiti, G. Pagano, G. Dervenoulas, T. Yousaf, H. Wilson, M. Politis (London, United Kingdom)

    Objective: We evaluated regional cerebral blood flow (CBF) levels in a cohort of early drug-naïve patients with Parkinson’s disease, and we explored for associations between…
  • 2019 International Congress

    Evidence of altered Serotonergic Network in Parkinson’s disease by using a multi-modal MRI and PET imaging approach

    SP. Caminiti, Z. Chappell, A. Carotenuto, G. Dervenoulas, T. Yousaf, G. Pagano, H. Wilson, M. Politis (London, United Kingdom)

    Objective: This study aims to assess how serotonergic pathological derangement may produce alterations in Parkinson’s disease (PD) functional connectivity, by means of a multimodal neuroimaging…
  • 2019 International Congress

    White matter abnormalities correlate with clinical features in PSP patients

    A. Campabadal, A. Abos, B. Segura, HC. Baggio, C. Uribe, A. Garrido, A. Camara, E. Muñoz, F. Valldeoriola, MJ. Martí, C. Junqué, Y. Compta (Barcelona, Spain)

    Objective: To detect white matter abnormalities in PSP patients and their correlation with motor and cognitive impairment. Background: Progressive Supranuclear Palsy (PSP) is a tauopathy…
  • 2019 International Congress

    Tracking cortical changes throughout cognitive decline in Parkinson’s disease: a longitudinal MRI study

    E. Canu, F. Agosta, T. Stojković, S.. Basaia, I. Stankovic, V. Markovic, I. Petrović, E. Stefanova, V. Kostic, M. Filippi (Milan, Italy)

    Objective: To investigate longitudinal cortical thinning (CT) in Parkinson’s disease (PD) patients with normal cognition (PD-CN), stable mild cognitive impairment (PD-MCIs), and patients who convert…
  • « Previous Page
  • 1
  • …
  • 1181
  • 1182
  • 1183
  • 1184
  • 1185
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley